Literature DB >> 14620133

Interactions between coagulation and inflammation.

Steven M Opal1.   

Abstract

The coagulation system evolved as a mechanism to limit the loss of vital elements from the internal milieu following mechanical injury to the circulatory system. The innate immune system developed as a rapid response system to detect and clear microbial invaders that have breached the integument of multicellular organisms. The coagulation and innate immunity systems coevolved from a common ancestral substrate early in eukaryotic development, and these 2 systems retain a highly integrated and coregulated circuitry of signals and control elements that defend the host following tissue injury and microbial invasion. Advances in the understanding of the molecular mechanisms that control clotting and inflammation have led to the successful development of recombinant human activated protein C for the treatment of human septic shock. Optimal use of this and other anticoagulant agents in sepsis will necessitate further basic research into the critical linkage between coagulation and innate immunity.

Entities:  

Mesh:

Year:  2003        PMID: 14620133     DOI: 10.1080/00365540310015638

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  27 in total

1.  Hypercoagulability: interaction between inflammation and coagulation in familial Mediterranean fever.

Authors:  Guzide Aksu; Can Ozturk; Kaan Kavakli; Ferah Genel; Necil Kutukculer
Journal:  Clin Rheumatol       Date:  2006-05-24       Impact factor: 2.980

2.  Polyphosphate modulates blood coagulation and fibrinolysis.

Authors:  Stephanie A Smith; Nicola J Mutch; Deepak Baskar; Peter Rohloff; Roberto Docampo; James H Morrissey
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-12       Impact factor: 11.205

3.  Antimicrobial effects of helix D-derived peptides of human antithrombin III.

Authors:  Praveen Papareddy; Martina Kalle; Ravi K V Bhongir; Matthias Mörgelin; Martin Malmsten; Artur Schmidtchen
Journal:  J Biol Chem       Date:  2014-09-08       Impact factor: 5.157

4.  Does the oxidation of methionine in thrombomodulin contribute to the hypercoaguable state of smokers and diabetics?

Authors:  Wesley E Stites; Jeffrey W Froude
Journal:  Med Hypotheses       Date:  2006-10-24       Impact factor: 1.538

5.  Arterial thrombosis in the context of HCV-associated vascular disease can be prevented by protein C.

Authors:  Philipp Blüm; Joachim Pircher; Monika Merkle; Thomas Czermak; Andrea Ribeiro; Hanna Mannell; Florian Krötz; Alexander Hennrich; Michael Spannagl; Simone Köppel; Erik Gaitzsch; Markus Wörnle
Journal:  Cell Mol Immunol       Date:  2016-04-18       Impact factor: 11.530

6.  Thrombin inhibition with dabigatran protects against high-fat diet-induced fatty liver disease in mice.

Authors:  Anna K Kopec; Nikita Joshi; Keara L Towery; Karen M Kassel; Bradley P Sullivan; Matthew J Flick; James P Luyendyk
Journal:  J Pharmacol Exp Ther       Date:  2014-08-19       Impact factor: 4.030

7.  Fructose-1,6-bisphosphate inhibits in vitro and ex vivo platelet aggregation induced by ADP and ameliorates coagulation alterations in experimental sepsis in rats.

Authors:  Luciana M de Oliveira; Melissa G Simões Pires; Alessandra B Magrisso; Terezinha P Munhoz; Rafael Roesler; Jarbas R de Oliveira
Journal:  J Thromb Thrombolysis       Date:  2009-08-25       Impact factor: 2.300

Review 8.  Systemic versus localized coagulation activation contributing to organ failure in critically ill patients.

Authors:  Marcel Levi; Tom van der Poll; Marcus Schultz
Journal:  Semin Immunopathol       Date:  2011-07-30       Impact factor: 9.623

Review 9.  The cancer stem cell: evidence for its origin as an injured autoreactive T cell.

Authors:  Peter Grandics
Journal:  Mol Cancer       Date:  2006-02-14       Impact factor: 27.401

10.  Heat shock inhibits lipopolysaccharide-induced tissue factor activity in human whole blood.

Authors:  Christoph Sucker; Kai Zacharowski; Matthias Thielmann; Matthias Hartmann
Journal:  Thromb J       Date:  2007-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.